CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of safety, wellness and power. It operates through the following segments: CURA and AegisThe CURA segment involves in advanced fatigue management products including wearable devices offering real-time alertness monitoring, and latest in online sleep or fatigue management and interactive learning. The Aegis segment develops advanced hydraulic pump and motor designs that provide higher power density, smaller size, and greater efficiency. The company was founded by Vernon E. Gleasman, James Y. Gleasman, and Keith E. Gleasman on September 25, 1996 and is headquartered in Rochester, NY.
Company profile
Ticker
CRGS
Exchange
Website
CEO
Richard A. Kaplan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Icahn Enterprises • Magna International • Aptiv • Adient • Autoliv • BorgWarner • Visteon • Dana • Allison Transmission • PHINIA ...
Former names
TORVEC INC
SEC CIK
Corporate docs
IRS number
161509512
CRGS stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
2 Sep 22
8-K
CurAegis Announces Immediate Cessation of Operations
19 Mar 21
8-K
Departure of Directors or Certain Officers
26 Feb 21
8-K
Entry into a Material Definitive Agreement
12 Jan 21
8-K
CurAegis Completes Sale of Aegis Assets
7 Dec 20
8-K
Entry into a Material Definitive Agreement
30 Nov 20
8-K
Departure of Directors or Certain Officers
17 Nov 20
10-Q
2020 Q3
Quarterly report
13 Nov 20
8-K
Departure of Directors or Certain Officers
12 Nov 20
8-K
Entry into a Material Definitive Agreement
26 Oct 20
Latest ownership filings
Financial summary
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 87.00 k | 87.00 k | 87.00 k | 87.00 k | 87.00 k | 87.00 k |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 72.25 k | 85.33 k | 144.58 k |
Cash used (since last report) | n/a | n/a | n/a | 3.08 mm | 3.64 mm | 6.17 mm |
Cash remaining | n/a | n/a | n/a | -3.00 mm | -3.55 mm | -6.08 mm |
Runway (months of cash) | n/a | n/a | n/a | -41.5 | -41.6 | -42.1 |
Institutional ownership, Q2 2023
0.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.00 k |
Total shares | 26.90 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Canandaigua National Bank & Trust | 14.90 k | $1.00 k |
Baxter Bros | 12.00 k | $0.00 |